PF04965842

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

A Renal Impairment Study for PF-04965842

A Hepatic Impairment Study for PF-04965842.

A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects

A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842.

Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants

Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants

A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants

A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin

Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Absorption, Metabolism, Excretion and Absolute Bioavailability

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects

First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects